Breaking News Instant updates and real-time market news.

SBPH

Spring Bank Pharmaceuticals

$14.43

0.05 (0.35%)

14:35
10/18/18
10/18
14:35
10/18/18
14:35

Adage Capital reports 6.18% passive stake in Spring Bank Pharmaceuticals

  • 19

    Oct

  • 27

    Nov

SBPH Spring Bank Pharmaceuticals
$14.43

0.05 (0.35%)

02/21/18
RILY
02/21/18
NO CHANGE
Target $30
RILY
Buy
Spring Bank remains undervalued hepatitis B play, says B. Riley FBR
B. Riley FBR analyst Madhu Kumar reiterates a Buy rating on Spring Bank Pharmaceuticals with a $30 price target following the company's Q4 results. The analyst says the company remains an undervalued mid-stage hepatitis B therapy play.
08/03/18
JMPS
08/03/18
NO CHANGE
Target $20
JMPS
Outperform
Spring Bank's early inarigivir data 'promising,' says JMP Securities
After Spring Bank Pharmaceuticals reported data on the third cohort in the Phase 2 ACHIEVE trial of inarigivir in HBV patients that met the primary endpoints, safety and antiviral activity, at both week 12 and week 24, JMP Securities analyst Liisa Bayko called the early data "promising." She thinks inarigivir has the potential to be an "integral piece to many iterations of combinations," which could "put the company in play" if the evidence builds. Bayko reiterated her Outperform rating and $20 price target on Spring Bank shares.
08/14/18
PIPR
08/14/18
INITIATION
Target $25
PIPR
Overweight
Spring Bank Pharmaceuticals initiated with an Overweight at Piper Jaffray
Piper Jaffray analyst Edward Tenthoff started Spring Bank Pharmaceuticals with an Overweight rating and $25 price target. The company has reported "encouraging" proof-of-concept data from the first three cohorts of the Phase II study of monotherapy inarigivir, in development to treat hepatitis B virus infection, Tenthoff tells investors in a research note. The analyst sees inarigivir as the "essential" immunomodulatory component in combination therapy to achieve an HBV functional cure.
10/09/18
JEFF
10/09/18
INITIATION
Target $28
JEFF
Buy
Spring Bank Pharmaceuticals initiated with a Buy at Jefferies
Jefferies analyst Maury Raycroft started Spring Bank Pharmaceuticals with a Buy rating and $28 price target. The company is developing inarigivir for hepatitis B virus and the drug is "de-risked" given its dose response and "excellent" safety profile, Raycroft tells investors in a research note. He believes inarigivir "could position as a backbone now and for the longer-term" in HBV treatment.

TODAY'S FREE FLY STORIES

15:30
02/21/19
02/21
15:30
02/21/19
15:30
General news
U.S. Treasury Market Summary »

U.S. Treasury Market…

CLX

Clorox

$158.67

3.36 (2.16%)

15:27
02/21/19
02/21
15:27
02/21/19
15:27
Earnings
Clorox sees long-term total company annual growth of 3%-5% »

Clorox sees long-term…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 04

    Mar

  • 28

    May

AAOI

Applied Optoelectronics

$14.45

-0.17 (-1.16%)

15:19
02/21/19
02/21
15:19
02/21/19
15:19
Options
Applied Optoelectronics options imply 25.6% move in share price post-earnings, above median historical move »

Pre-earnings options…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 26

    Feb

  • 27

    Feb

  • 28

    Feb

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

15:17
02/21/19
02/21
15:17
02/21/19
15:17
Technical Analysis
NASDAQ market internals summary »

Volume is above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

15:16
02/21/19
02/21
15:16
02/21/19
15:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IART

Integra LifeSciences

$55.50

3.58 (6.90%)

15:10
02/21/19
02/21
15:10
02/21/19
15:10
Recommendations
Integra LifeSciences analyst commentary  »

Piper reiterates…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

HYG

iShares iBoxx $ High Yield Corporate Bond

$85.43

-0.07 (-0.08%)

15:10
02/21/19
02/21
15:10
02/21/19
15:10
Options
Far downside ratio spread opened in High Yield Bond Fund »

Far downside ratio spread…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DWDP

DowDuPont

$55.19

-1.06 (-1.88%)

15:06
02/21/19
02/21
15:06
02/21/19
15:06
Hot Stocks
Corteva Agriscience announces U.S. launch of Enlist E3 soybeans »

Corteva Agriscience, the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Feb

  • 27

    Feb

  • 04

    Mar

  • 04

    Mar

  • 13

    Mar

  • 28

    May

EXAS

Exact Sciences

$82.81

-0.79 (-0.94%)

15:04
02/21/19
02/21
15:04
02/21/19
15:04
Options
EXACT Sciences options imply 15.0% move in share price post-earnings, above median historical move »

Pre-earnings options…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 22

    Feb

  • 18

    May

GE

General Electric

$10.05

-0.055 (-0.54%)

15:00
02/21/19
02/21
15:00
02/21/19
15:00
Options
100K GE Mar 8th 9 puts bought for 5c with shares flat at $10.10 »

100K GE Mar 8th 9 puts…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

APC

Anadarko

$43.81

-1.35 (-2.99%)

14:59
02/21/19
02/21
14:59
02/21/19
14:59
Periodicals
Anadarko says 4 injured in attack at Mozambique LNG project, Bloomberg reports »

Anadarko Petroleum said…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Apr

  • 22

    May

ALB

Albemarle

$88.17

5.35 (6.46%)

14:54
02/21/19
02/21
14:54
02/21/19
14:54
Recommendations
Albemarle analyst commentary  »

Albemarle price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 27

    Feb

  • 27

    Feb

PBR

Petrobras

$16.70

-0.01 (-0.06%)

14:53
02/21/19
02/21
14:53
02/21/19
14:53
Periodicals
Brazil minister says Petrobras TOR auction may occur in late 2019, Reuters says »

Brazil's Energy and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Feb

TI

Telecom Italia

$5.92

-0.12 (-1.99%)

14:51
02/21/19
02/21
14:51
02/21/19
14:51
Hot Stocks
Telecom Italia sees organic group EBITDA to decrease low single digit in 2019 »

TIM's Board of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

TSU

Tim Participacoes

$16.30

0.03 (0.18%)

14:50
02/21/19
02/21
14:50
02/21/19
14:50
Hot Stocks
Breaking Hot Stocks news story on Tim Participacoes »

TIM Participacoes trading…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ROKU

Roku

$51.60

-2.03 (-3.79%)

14:49
02/21/19
02/21
14:49
02/21/19
14:49
Options
Roku options imply 18.8% move in share price post-earnings, below median historical move »

Pre-earnings options…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

LKSD

LSC Communications

$9.23

-0.17 (-1.81%)

, QUAD

Quad/Graphics

$15.85

-0.42 (-2.58%)

14:47
02/21/19
02/21
14:47
02/21/19
14:47
Conference/Events
Quad/Graphics to host special shareholder meeting »

Special Shareholder…

LKSD

LSC Communications

$9.23

-0.17 (-1.81%)

QUAD

Quad/Graphics

$15.85

-0.42 (-2.58%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

  • 22

    Feb

FB

Facebook

$160.21

-2.4 (-1.48%)

14:46
02/21/19
02/21
14:46
02/21/19
14:46
Periodicals
Kids advocacy groups urge FTC to probe Facebook over game purchases, Adweek says »

Childrens' advocacy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Feb

  • 25

    Feb

  • 03

    Mar

QUAD

Quad/Graphics

$15.80

-0.47 (-2.89%)

, LKSD

LSC Communications

$9.23

-0.17 (-1.81%)

14:41
02/21/19
02/21
14:41
02/21/19
14:41
Conference/Events
LSC Communications to host special shareholder meeting »

Special Shareholder…

QUAD

Quad/Graphics

$15.80

-0.47 (-2.89%)

LKSD

LSC Communications

$9.23

-0.17 (-1.81%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

GIL

Gildan Activewear

$34.04

-0.13 (-0.38%)

14:37
02/21/19
02/21
14:37
02/21/19
14:37
Downgrade
Gildan Activewear rating change  »

Gildan Activewear…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

TSU

Tim Participacoes

$16.30

0.03 (0.18%)

14:37
02/21/19
02/21
14:37
02/21/19
14:37
Earnings
Tim Participacoes releases guidance for 2019-2021 »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CTRP

Ctrip

$32.55

-1.24 (-3.67%)

14:35
02/21/19
02/21
14:35
02/21/19
14:35
Options
Ctrip.com put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Mar

  • 04

    Mar

  • 20

    Mar

NAII

Natural Alternatives International

$11.15

(0.00%)

14:34
02/21/19
02/21
14:34
02/21/19
14:34
Hot Stocks
Natural Alternatives International hires David Brook for sports nutrition unit »

Natural Alternatives…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NTDOY

Nintendo

$0.00

(0.00%)

14:24
02/21/19
02/21
14:24
02/21/19
14:24
Hot Stocks
Nintendo of America president, COO Reggie Fils-Aime to retire »

Nintendo announced that,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FCAU

Fiat Chrysler

$14.83

-0.21 (-1.40%)

14:23
02/21/19
02/21
14:23
02/21/19
14:23
Hot Stocks
Fiat Chrysler to propose EUR0.65 per share dividend »

Fiat Chrysler Automobiles…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.